ISA Virtual Workshop: Gaps In Diagnosis And Management Of AL Amyloidosis

The International Society of Amyloidosis (ISA) is hosting a virtual workshop on November 10, 2021 with physicians from amyloidosis centers around the world.

Proper management of patients with AL amyloidosis requires a multidisciplinary team. This workshop will be aimed at all those who participate in the management of patients with AL amyloidosis, particularly hematologists, cardiologists, neurologists, nephrologists, pathologists, laboratory specialists and stem cell transplant physicians.

During this hour-long workshop, the presenters will review the strategies to achieve an early and adequate diagnosis. The role of autologous transplantation will be discussed, with a focus on Latin America, where access to novel drugs is not universal. Finally, the impact of daratumumab treatment and its place in the therapeutic algorithm will be analyzed. Presentations will be followed by 15 minutes of Q&A and discussion.

Introduction
Dr. Eloisa Riva, MD, Hospital de Clinicas (Montevideo, Uruguay)

Steps Towards Early and Accurate Diagnosis of AL Amyloidosis
Dr. M. Teresa Cibeira, MD, PhD, Hospital Clínic of Barcelona (Barcelona, Spain)

The Role of Autologous Stem Cell Transplantation in the Current Era (Latin American perspective)
Dr. Eloisa Riva, MD, Hospital de Clinicas (Montevideo, Uruguay)

When and How to Use Daratumumab
Dr. Simon Gibbs, MBBS FRACP FRCPA, Victorian and Tasmanian Amyloidosis Service (Melbourne, Victoria, Australia)

Q&A and Discussion (live)